These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38175687)

  • 41. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
    Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
    Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.
    Li H; Luo F; Jiang X; Zhang W; Xiang T; Pan Q; Cai L; Zhao J; Weng D; Li Y; Dai Y; Sun F; Yang C; Huang Y; Yang J; Tang Y; Han Y; He M; Zhang Y; Song L; Xia JC
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35277458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy.
    Xu T; Liu Z; Huang L; Jing J; Liu X
    Front Immunol; 2022; 13():1057850. PubMed ID: 36532066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
    Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.
    Wang J; Gu Q; Liu Y; Huang X; Zhang J; Liu B; Li R; Linghu H
    Exp Cell Res; 2024 Jun; 439(2):114100. PubMed ID: 38797258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer.
    Zhao Z; Wang Q; Zhao F; Ma J; Sui X; Choe HC; Chen P; Gao X; Zhang L
    BMC Genomics; 2024 Jan; 25(1):1. PubMed ID: 38166541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-associated macrophages mediate gastrointestinal stromal tumor cell metastasis through CXCL2/CXCR2.
    Cai H; Chen Y; Chen X; Sun W; Li Y
    Cell Immunol; 2023 Feb; 384():104642. PubMed ID: 36577281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing.
    Zhao S; Ye B; Chi H; Cheng C; Liu J
    Heliyon; 2023 Jul; 9(7):e17454. PubMed ID: 37449151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Zhang Y; Zhang X; Huang X; Tang X; Zhang M; Li Z; Hu X; Zhang M; Wang X; Yan Y
    Stem Cell Res Ther; 2023 Feb; 14(1):15. PubMed ID: 36721217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deciphering the heterogeneity dominated by tumor-associated macrophages for survival prognostication and prediction of immunotherapy response in lung adenocarcinoma.
    Sun J; Guo H; Nie Y; Zhou S; Zeng Y; Sun Y
    Sci Rep; 2024 Apr; 14(1):9276. PubMed ID: 38653742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer.
    Mo J; Zhang L; Li H; Duan H; Wang D; Zhao X; Xie Y
    J Ovarian Res; 2022 May; 15(1):61. PubMed ID: 35568893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.
    Gao Y; Shi H; Zhao H; Yao M; He Y; Jiang M; Li J; Li Z; Su S; Liu T; Yin C; Liao X; Yue W
    Clin Transl Med; 2023 Sep; 13(9):e1416. PubMed ID: 37712139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
    Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
    Front Immunol; 2020; 11():89. PubMed ID: 32184777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis.
    Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109422. PubMed ID: 36410184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
    Liu L; Wang X; Li X; Wu X; Tang M; Wang X
    Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition.
    Zhang S; Geng J; Shan F; Shan Y; Griffin N; Wu B; Wang X
    Int Immunopharmacol; 2023 May; 118():110064. PubMed ID: 36989897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.
    Wang Z; Liu Y; Wang M; Zhao J
    J BUON; 2020; 25(2):797-804. PubMed ID: 32521870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.